Glanzmann thrombasthenia: The need for epidemiological studies

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 11, 2009, Pages 1875-1877

  Nurden, A T ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; BLOOD CLOTTING FACTOR 7; FIBRINOGEN RECEPTOR; VON WILLEBRAND FACTOR;

BLEEDING; CLINICAL EVALUATION; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; EXON; FAMILY HISTORY; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE MAPPING; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLANZMANN DISEASE; HUMAN; INDIA; ITALY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

EPIDEMIOLOGIC STUDIES; HUMANS; MUTATION; THROMBASTHENIA;

EID: 70449455550     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03597.x     Document Type: Note

References (17)

1. Nurden AT, George JN, Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber S. Inherited abnormalities of the platelet membrane: Glanzmann Thrombasthenia, Bernard-Soulier syndrome, and other disorders. Hemostasis and Thrombosis 2006, 987-1010. In, eds, 4th edn, Philadelpia, Lippincott, Williams & Wilkins
2. Bray PF, Shuman MA. Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann thrombasthenia. Blood 1990, 75:881-8.
3. Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991, 88:3160-4.
4. Mitchell WB, Li J, Singh F, Michelson AD, Bussel J, Coller BS, French DL. Two novel mutations in the alphaIIb calcium-binding domains identify hydrophobic regions essential for alphaIIbbeta3 biogenesis. Blood 2003, 101:2268-76.
5. Rosenberg N, Hauschner H, Peretz H, Mor-Cohen R, Landau M, Shenkman B, Kenet G, Coller BS, Awidi AA, Seligsohn U. A 13-bp deletion in alphaIIb gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia. J Thromb Haemost 2005, 3:2764-72.
6. Svensson L, Howarth K, Mcdowall A, Patzak I, Evans R, Ussar S, Moser M, Metin A, Fried M, Tomlinson I, Hogg N. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 2009, 15:306-12.
7. D'Andrea G, Colaizzo D, Vecchione G, Grandone E, Di Minno G, Margaglione M. Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost 2002, 87:1034-42.
8. Nelson EJ, Nair SC, Peretz H, Coller BS, Seligsohn U, Chandy M, Srivastava A. Diversity of Glanzmann thrombasthenia in Southern India: 10 novel mutations identified among 15 unrelated patients. J Thromb Haemost 2006, 4:1730-7.
9. Peretz H, Rosenberg N, Landau M, Usher S, Nelson EJ, Mor-Cohen R, French DL, Mitchell BW, Nair SC, Chandy M, Coller BS, Srivastava A, Seligsohn U. Molecular diversity of Glanzmann thrombasthenia in Southern India: new insights into mRNA splicing and structure-function correlations of αIIbβ3 integrin (ITGA2B, ITGB3). Hum Mutat 2006, 27:359-69.
10. Kannan M, Ahmad F, Yadav B, Kumar R, Choudry V, Saxena R. Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann's thrombasthenia. J Thromb Haemost 2009
11. Xie J, Pabon D, Jayo A, Butta N, Gonzalez-Manchon C. Type I Glanzmann thrombasthenia caused by an apparently silent β3 mutation that results in aberrant splicing and reduced β3 mRNA. Thromb Haemost 2005, 93:897-903.
12. Jacquelin B, Tuleja E, Kunicki TJ, Nurden P, Nurden AT. Analysis of platelet membrane glycoprotein polymorphisms in Glanzmann thrombasthenia showed the French gypsy mutation in the αIIb gene to be strongly linked to the HPA-1b polymorphism in β3. J Thromb Haemost 2003, 1:573-5.
13. Cheli Y, Jensen D, Marchese P, Habart D, Wiltshire T, Cooke M, Fernandez JA, Ware JA, Ruggeri ZM, Kunicki TJ. The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice. Blood 2008, 111:1266-73.
14. Hodivala-Dilke K, McHugh KP, Tsarikis DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999, 103:229-38.
15. Feng X, Novack DV, Faccio R, Ory DS, Ava K, Boyer MI, McHugh KP, Ross FP, Teitelbaum SL. A Glanzmann's mutation in β3 integrin specifically impairs osteoclast function. J Clin Invest 2001, 107:1137-44.
16. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nat Med 2002, 8:27-34.
17. Fang J, Hodivala-Dilke K, Johnson BD, Lu LM, Hynes RO, White GC, Wilcox DA. Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia. Blood 2005, 106:2671-9.